<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37184366</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1477-0962</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Lupus</Title><ISOAbbreviation>Lupus</ISOAbbreviation></Journal><ArticleTitle>Lupus enteritis: A 10-year experience in a single Latin American center.</ArticleTitle><Pagination><StartPage>910</StartPage><EndPage>919</EndPage><MedlinePgn>910-919</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/09612033231175782</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The objective is to compare the clinical and laboratory characteristics of systemic lupus erythematosus (SLE) patients with and without lupus enteritis (LE) and to identify the factors associated with the occurrence of LE.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We performed a retrospective, case-control study in hospitalized patients with SLE who were admitted to our tertiary hospital between January 2012 and December 2021. Sixteen LE patients (cases) were matched (1:3 ratio) for sex and birth year with 48 non-LE patients (controls). Univariable and multivariable logistic regression analyses were used to identify the variables associated with LE.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 2,479 SLE patients who were admitted to our hospital as inpatients, 16 (0.65%) were diagnosed as having LE. All patients, cases and controls, were of Mestizo ethnicity. SLE was diagnosed simultaneously with the first episode of LE in 10 (62.5%) patients. The median time from SLE diagnosis to the first episode of LE was 7 (IQR 0-78)&#xa0;months. LE patients had a shorter median disease duration [7 (0-78) vs 34 (9.5-79)&#xa0;months], and a significantly longer hospital stay (28.3 &#xb1; 15.8 vs 6.5 &#xb1; 7.9&#xa0;days, <i>p</i> &lt; 0.001) than non-LE patients. Most LE patients (93.8%) had concomitant lupus nephritis. LE patients had higher SLEDAI-2K scores than those without LE (20.5 &#xb1; 9.4 vs 9.8 &#xb1; 10.4, <i>p</i> &lt; 0.001). By multivariable analysis, a higher SLEDAI-2K score (OR 1.10, 95% CI 1.02-1.18; <i>p</i> = 0.015) was independently associated with LE occurrence after adjusting for cutaneous involvement, lymphocyte count, serum creatinine, and serum complement C4. Recurrence was observed in two patients (12.5%), both with a bowel wall thickening &gt; 8&#xa0;mm. The two patients with large intestine-dominant LE developed intestinal pseudo-obstruction. No patient had life-threatening complications (intestinal hemorrhage, infarction, or perforation), and there were no deaths induced directly by LE itself.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In patients of Mestizo ethnicity, LE occurs during the early course of SLE, frequently is one of the presenting manifestations of SLE, and in most cases, it presents with concomitant lupus nephritis. Higher levels of disease activity at diagnosis were independently associated with LE occurrence and when recurrences occur, they do so in the context of severe wall thickness.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mu&#xf1;oz-Urbano</LastName><ForeName>Marcela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Internal Medicine, School of Medicine, Universidad de Antioquia, Hospital San Vicente Fundaci&#xf3;n, Medell&#xed;n, Colombia.</Affiliation><Identifier Source="RINGGOLD">161932</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanchez-Bautista</LastName><ForeName>Juli&#xe1;n</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Internal Medicine, School of Medicine, Universidad de Antioquia, Hospital San Vicente Fundaci&#xf3;n, Medell&#xed;n, Colombia.</Affiliation><Identifier Source="RINGGOLD">161932</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ram&#xed;rez</LastName><ForeName>Andr&#xe9;s</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Internal Medicine, School of Medicine, Universidad de Antioquia, Hospital San Vicente Fundaci&#xf3;n, Medell&#xed;n, Colombia.</Affiliation><Identifier Source="RINGGOLD">161932</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santamar&#xed;a-Alza</LastName><ForeName>Yeison</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Internal Medicine, School of Medicine, Universidad de Antioquia, Hospital San Vicente Fundaci&#xf3;n, Medell&#xed;n, Colombia.</Affiliation><Identifier Source="RINGGOLD">161932</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quintero-Gonz&#xe1;lez</LastName><ForeName>Diana C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Internal Medicine, School of Medicine, Universidad de Antioquia, Hospital San Vicente Fundaci&#xf3;n, Medell&#xed;n, Colombia.</Affiliation><Identifier Source="RINGGOLD">161932</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vanegas-Garc&#xed;a</LastName><ForeName>Adriana-Luc&#xed;a</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Internal Medicine, School of Medicine, Universidad de Antioquia, Hospital San Vicente Fundaci&#xf3;n, Medell&#xed;n, Colombia.</Affiliation><Identifier Source="RINGGOLD">161932</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>V&#xe1;squez</LastName><ForeName>Gloria</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Internal Medicine, School of Medicine, Universidad de Antioquia, Hospital San Vicente Fundaci&#xf3;n, Medell&#xed;n, Colombia.</Affiliation><Identifier Source="RINGGOLD">161932</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez</LastName><ForeName>Luis A</ForeName><Initials>LA</Initials><Identifier Source="ORCID">0000-0002-6523-3919</Identifier><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Internal Medicine, School of Medicine, Universidad de Antioquia, Hospital San Vicente Fundaci&#xf3;n, Medell&#xed;n, Colombia.</Affiliation><Identifier Source="RINGGOLD">161932</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lupus</MedlineTA><NlmUniqueID>9204265</NlmUniqueID><ISSNLinking>0961-2033</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008181" MajorTopicYN="Y">Lupus Nephritis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007843" MajorTopicYN="N" Type="Geographic">Latin America</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004751" MajorTopicYN="Y">Enteritis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword><Keyword MajorTopicYN="N">abdominal pain</Keyword><Keyword MajorTopicYN="N">lupus enteritis</Keyword><Keyword MajorTopicYN="N">mesenteric vasculitis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>19</Day><Hour>13</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>15</Day><Hour>13</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>15</Day><Hour>9</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37184366</ArticleId><ArticleId IdType="doi">10.1177/09612033231175782</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>